Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Operational Other
confidence 75%
filed 2026-07-16
This 6-K furnishes a press release announcing Buenaventura's second-quarter 2026 production and sales volumes across its mining operations (gold, silver, lead, zinc, copper), along with updated full-year 2026 guidance for several mines. While the disclosure includes operational metrics and revised production guidance, it does not constitute a formal earnings release with financial results (net income, revenue, or comprehensive financial statements). The focus is on operational production metrics and volume sold per metal, making this an operational disclosure rather than a financial results announcement. Material to investors assessing the company's operational performance and production trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-16
Item 2.02
Clearway Energy disclosed operational data for the three and six months ended June 30, 2026 via an "Operational Update Presentation" furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition). The presentation contains key performance metrics including compensable generation, plant availability, and performance indices for 2Q 2026 and YTD 2026, with explicit disclosure that 2Q generation fell short of guidance expectations due to lower wind resources. This constitutes a material operational and financial results disclosure typical of earnings-related announcements.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-16
Item 8.01
This Item 8.01 disclosure announces a ticker symbol change from "GRAF" to "TONT" in anticipation of the closing of a previously announced business combination between Graf Global Corp. and BIG3 HoldCo LLC. The Business Combination Agreement was entered into on June 12, 2026, and the filing explicitly states the business combination is "expected to close in fourth quarter of 2026." While the immediate disclosure concerns the ticker change, the substance is the material acquisition/merger activity—the change is a direct consequence of the pending business combination and signals material progress toward closing. This is a change of control transaction that would materially affect investor interests.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-16
Item 7.01
Insmed announced positive 12-month safety and efficacy data from an ongoing open-label extension study of treprostinil palmitil inhalation powder (TPIP) in pulmonary arterial hypertension patients. The disclosure demonstrates sustained clinical improvements across secondary efficacy measures (6MWD, NT-proBNP, WHO Functional Class, REVEAL Lite 2.0 score) and favorable safety profile, supporting advancement to Phase 3 PALM-PAH trial. This is a material clinical milestone for an investigational drug in mid-to-late stage development that would affect investor assessment of the company's pipeline and commercial prospects.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-16
Item 1.01
AtaiBeckley Inc. entered into a definitive Agreement and Plan of Merger with Eli Lilly and Company on July 15, 2026, whereby Lilly will acquire all outstanding shares of AtaiBeckley for $6.75 per share in cash plus contingent value rights worth up to $2.50 per share, representing approximately $2.8 billion in upfront equity value plus $1.0 billion in potential milestone payments.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-16
Item 2.02
Bank7 Corp. disclosed its Q2 2026 financial results via press release on July 16, 2026, reporting net income of $8.35 million, EPS of $0.87, and total assets of $1.91 billion. The filing includes a full earnings press release (Exhibit 99.1) with condensed consolidated financial statements, net interest margin analysis, and management commentary from the CEO. This is a standard quarterly earnings disclosure under Item 2.02, material to investors assessing the company's financial performance and condition.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 82%
filed 2026-07-16
Item 1.01
Vistra Corp. amended two material financing facilities: an Accounts Receivable Securitization Facility (increasing aggregate commitment from $1.1 billion to $1.25 billion and extending the term to July 2027) and a Repurchase Facility with MUFG Bank (extending the term to July 2027). These amendments modify existing direct financial obligations and increase available liquidity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
Gyre Therapeutics appointed three new directors to its Board effective August 1, 2026: Yue Xiong, Ph.D. as a Class I director, Maxwell Kirkby as a Class II director (also appointed to the Compensation Committee), and Claire Weston, Ph.D. as a Class III director (also appointed to the Audit Committee). This materially affects board composition and committee structure at the biopharmaceutical company.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-07-16
Item 1.02
Arbutus terminated its RSV Agreement with Genevant, incurring a $1.0 million termination fee. The termination is part of a broader financial restructuring that includes receipt of approximately $178 million from Moderna and announcement of up to $230 million in capital returns to shareholders.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-16
Item 5.02
The Board approved one-time lump sum cash bonuses for CEO Lindsay Androski and CFO Tuan Nguyen tied to litigation settlement proceeds, with Androski receiving 1.5% of noncontingent payments ($178M), 2.0% of contingent proceeds, and 2.5% of Pfizer/BioNTech litigation proceeds, and Nguyen receiving 0.25% of noncontingent proceeds and potential future bonuses.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 75%
filed 2026-07-16
Item 8.01
Arbutus and Genevant filed three international patent infringement lawsuits against Pfizer and BioNTech seeking monetary relief and injunctions against their mRNA-LNP COVID-19 vaccines, asserting Arbutus's LNP patent portfolio.
View raw filing on EDGAR →
6-K
Financial Other
confidence 75%
filed 2026-07-16
EX-99.1
BrainsWay announced a $500,000 minority-stake investment in Sound Minds Behavioral, a behavioral health platform. This is a strategic equity investment that does not constitute a material acquisition (no control or change of control), nor a typical debt issuance or dilutive equity issuance by BrainsWay itself. The investment represents a financial commitment and strategic partnership that would be material to investors assessing the company's capital allocation and growth strategy, but it fits most naturally under financial_other as a minority investment activity that does not match the specific categories of ma_activity, debt_issuance, or dilutive_issuance.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-16
EX-99.1
TOP Ships announced the cancellation of a previously contemplated acquisition of a Dubai real estate portfolio, with a $23.5 million advance payment to be refunded. This represents termination of a material transaction that was announced on November 28, 2025, and involves a significant capital commitment being released back to the company. The decision by the special committee of independent directors and the material financial impact (refund of $23.5 million) constitute a material M&A activity event under the termination of a material acquisition.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-16
Item 7.01
The press release announces a cash dividend declaration of $0.30 per share, payable August 4, 2026, to stockholders of record as of July 28, 2026. This represents a 20% increase over the prior dividend and marks the 31st consecutive year of dividend payments. The disclosure is a straightforward dividend distribution event material to shareholders.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-16
Item 8.01
Star Group, L.P. declared a quarterly distribution of $0.1975 per common unit for the three months ended June 30, 2026, with a record date of July 27, 2026 and payment date of August 5, 2026. This is a routine but material distribution to unitholders, consistent with the company's status as a master limited partnership (MLP) that regularly distributes cash to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-16
Item 2.02
Great Southern Bancorp issued a press release on July 15, 2026, reporting preliminary financial results for the quarter ended June 30, 2026, disclosing earnings per diluted common share of $1.43 (compared to $1.72 in Q2 2025), net income of $15.8 million, and key metrics including net interest income, asset quality, and capital ratios. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-16
Item 2.02
This is a clear earnings release disclosing Westamerica Bancorporation's second quarter 2026 financial results. The press release reports net income of $27.4 million, diluted EPS of $1.17, and provides comprehensive financial highlights including net interest income, noninterest income/expense, and key operating ratios. The Item 2.02 classification and attached press release (Exhibit 99.1) are standard for quarterly earnings disclosures.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-16
Item 7.01
The press release explicitly announces that Donegal Group Inc.'s board of directors declared a regular quarterly cash dividend of $0.1925 per share for Class A common stock and $0.175 per share for Class B common stock, payable on August 14, 2026. This is a straightforward dividend distribution disclosure, a material event affecting shareholders' assessment of capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Financial Other
confidence 75%
filed 2026-07-16
EX-99.1
This press release discloses management's estimate of net asset value (NAV) as of June 30, 2026, showing a 94% increase from the previously reported NAV on March 2, 2026, translating to $300.26 per common share and $72.22 per fully diluted share. While NAV estimates are financial disclosures material to investors in valuation-focused companies like shipping firms, this is neither a formal earnings release (which would report audited or reviewed financial results) nor a periodic financial report, but rather a management valuation announcement that would affect investor assessment of the company's value.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-16
Item 8.01
ENB Financial Corp declared a $0.18 per share third quarter cash dividend payable on September 15, 2026, to shareholders of record on August 14, 2026. This is a straightforward dividend declaration disclosed in Item 8.01 (Other Events) with a press release attached as Exhibit 99. The declaration of a regular quarterly dividend is material to shareholders as it represents a return of capital and signals management's confidence in the company's financial position.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-16
Item 8.01
The Board of Directors declared a third quarter dividend of $0.10 per share on Common Stock with a record date of August 31, 2026 and payment date of September 14, 2026. This is a routine but material dividend declaration by a REIT, which is a standard capital distribution to shareholders and would affect investor assessment of the registrant's capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-16
EX-99.1
Silicom announced a new Design Win from an existing blue-chip customer for a custom high-speed server adapter, with revenue expected to scale from ~$3 million in 2026 to ~$10 million in 2027. This represents a material operational and commercial milestone—a significant new product contract with a major customer that will substantially increase revenue—but does not fit the discrete event categories of M&A, earnings release, or other named types. The disclosure is clearly operational (a new customer contract/product win) and material to investor assessment of growth prospects.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-16
Item 5.07
Entera Bio held its 2026 Annual Meeting of Shareholders on July 14, 2026, with voting results disclosed covering ten proposals including director elections (Sean Ellis, Steven D. Rubin, Geno H. Germano), executive and director compensation approvals, equity plan amendments, and auditor ratification.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-16
Item 5.02
Shareholders approved an amendment to the 2018 Equity Incentive Plan increasing the share pool by 2,500,000 ordinary shares, expanding the equity available for compensatory grants to officers and directors.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-07-16
Item 8.01
Columbus Circle Capital Corp III consummated its IPO on July 10, 2026, raising $230 million in gross proceeds from the sale of 23 million units at $10.00 per unit, plus an additional $6.65 million from concurrent private placement sales. While this is a significant capital-raising event, it does not fit neatly into the standard 8-K taxonomy: it is not an earnings release, M&A activity, debt issuance, or dilutive equity issuance in the traditional sense (the company is a blank-check SPAC with no operating business). The disclosure is material to investors as it establishes the company's capitalization and trust account structure, but the event type is ambiguous—it could be characterized as a capital formation event, a governance milestone, or an operational milestone for a newly public entity. Given the domain is unclear and the event does not fit a specific named category, `other_material` is most appropriate.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-16
Item 5.07
IRIDEX Corporation held its 2026 Annual Meeting of Stockholders on July 10, 2026, with voting results confirming the election of five directors (Nick Chen, Beverly A. Huss, Patrick Mercer, William Moore, and Scott Shuda), ratification of BPM LLP as independent auditor, and advisory approval of named executive officer compensation.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-16
Item 7.01
The Board disclosed findings from an investigation into an alleged stealth proxy campaign involving at least one director that violated fiduciary duties and federal securities laws (Rules 14a-3, 14a-6, 14a-1, and SEC Rule 13D regarding undisclosed groups) during the 2026 Annual Meeting process.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-07-16
KB Financial Group disclosed an update to its board resolution to cancel 3,581,623 treasury shares valued at approximately KRW 600 billion, scheduled for cancellation on December 23, 2026. Treasury share cancellation is a form of capital return to shareholders that reduces the share count and increases earnings per share, functionally similar to a dividend distribution or share repurchase program. The materiality of the transaction (nearly 600 billion KRW) and its direct impact on shareholder equity and per-share metrics support classification as a material capital distribution event.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 92%
filed 2026-07-16
KB Financial Group completed a share buyback program acquiring 3,581,623 common shares (1.01% of outstanding shares) for approximately KRW 600 billion from April 24 to July 14, 2026. Share repurchase programs are classified as returns of capital to shareholders under the dividend_distribution category, and the scale (600 billion KRW, ~1% of shares) is material to a reasonable investor's assessment of capital allocation and shareholder value.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-16
EX-99
The exhibit discloses the RBI-approved appointment of Mr. Rajiv Kumar as Part-time Chairman of HDFC Bank effective July 15, 2026, for a three-year term under Section 10B(1A)(i) of the Banking Regulation Act, 1949. This is a material executive appointment of a senior leadership position (Chairman) that would affect a reasonable investor's assessment of the bank's governance and leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
The filing discloses both a departure (Helen Meates stepping down as CFO effective October 1, 2026) and an appointment (Arun Kalra appointed as CFO effective the same date). While both events occur, the principal disclosed action centers on the appointment of Kalra to the CFO role, with the departure framed as a transition. The filing emphasizes Kalra's qualifications, tenure at the firm since 2016, and the Board's confidence in his appointment, making the appointment the salient event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-16
Item 2.02
ManpowerGroup issued a press release on July 16, 2026 announcing quarterly and six-month financial results for the periods ended June 30, 2026 and 2025. The disclosure includes detailed revenue ($4.9 billion, +8% reported), earnings per share ($1.13 diluted vs. prior year loss of $1.44), and operating results across business segments. This is a standard earnings release under Item 2.02, material to investors assessing the company's financial performance and operational trends.
View raw filing on EDGAR →
6-K
Other material
confidence 65%
filed 2026-07-16
EX-99.1
This exhibit bundles multiple material developments: (1) fiscal 2026 annual report filing with audited financials showing $6.4M cash and $7.3M shareholders' equity; (2) a commercial supply agreement with Fosun Diagnostics for ImmuneSelect across six Southeast Asian markets; (3) completion of a preferred investment option exercise generating $3.3M in gross proceeds; and (4) Nasdaq compliance restoration following a 1-for-25 share consolidation. While each component is material (financing, commercial progress, regulatory compliance), the exhibit is a CEO shareholder update synthesizing multiple discrete events rather than a single classified event type. The financing and commercial agreement are most significant, but the exhibit's primary function is to contextualize the annual report filing and provide strategic commentary rather to announce a single discrete transaction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-16
Item 2.02
Prologis announced second quarter 2026 financial results on July 16, 2026, reporting net earnings attributable to common stockholders of $1.061 billion (versus $570 million in Q2 2025) and Core FFO of $1.559 billion (versus $1.396 billion year-over-year), along with full-year 2026 guidance and comprehensive operating metrics.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-07-16
Item 5.02
Dr. Richard Glickman resigned as director and chairman of the Board effective immediately on July 15, 2026, after serving in that role for over 14 years. Michael Heffernan assumes the chairman role.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-16
Item 1.01
Cardiff Oncology completed a registered direct offering of approximately 8.6 million shares of common stock and accompanying warrants at $1.05 per share, with officers and directors purchasing an additional ~731,707 insider shares at $1.435 per share, generating approximately $10.05 million in gross proceeds for working capital and general corporate purposes.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-16
Item 2.01
Baker Hughes completed its acquisition of Chart Industries, Inc. on July 16, 2026, for $210.00 per share in cash consideration. Chart, with $4.3 billion in annual revenue, becomes a third operating segment and is expected to generate $325 million in annualized cost synergies within three years.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-16
Item 2.03
Baker Hughes entered into two term loan credit agreements totaling $2.0 billion ($1.0 billion from Bank of America and $1.0 billion from UniCredit) on July 15, 2026, with a 2-year maturity to finance the Chart Industries acquisition and related transaction costs. The company also issued $6.5 billion and €3.0 billion in senior notes to fund the acquisition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-16
Item 2.01
Baker Hughes completed its acquisition of Chart Industries on July 16, 2026, in an all-cash merger at $210.00 per share. Chart Industries ceased to exist as an independent public company and became an indirect subsidiary of Baker Hughes, with all outstanding debt redeemed and credit facilities prepaid.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-16
Item 3.01
Chart Industries notified the NYSE on July 16, 2026 of the completion of the merger and requested withdrawal of its listing, with plans to file Form 25 for delisting and Form 15 for deregistration.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-16
Item 5.02
Seven directors (Andrew R. Cichocki, Paula M. Harris, Linda A. Harty, Paul E. Mahoney, David M. Sagehorn, Spencer S. Stiles, and Roger A. Strauch) and three executive officers (Gerald F. Vinci, Joseph R. Brinkman, and Herbert G. Hotchkiss) departed effective upon consummation of the merger, while one officer (Joseph A. Belling) continued.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-16
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Pittsburgh. Schedule A details multiple debt securities issued on trade dates of 7/13/2026 and 7/14/2026, with principal amounts totaling approximately $2.5 billion across fixed-rate bonds and variable-rate floaters with maturities ranging from 2027 to 2033. This is a classic debt issuance under Item 2.03, and the registrant explicitly notes that "consolidated obligations issuance is material to the FHLBank."
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-16
Item 3.02
The filing discloses an unregistered sale of 194,814 common shares of beneficial interest to accredited investors in a private placement for $6.74 million, exempt under Section 4(a)(2) and Regulation D. This is a classic dilutive equity issuance that increases share count and raises capital, materially affecting existing shareholders' ownership percentages and the registrant's capital structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-16
Item 2.02
River Financial Corporation issued a press release on July 16, 2026 announcing quarterly and year-to-date financial results for the period ended June 30, 2026. The disclosure includes comprehensive financial metrics: year-to-date net income increased 36.3% to $28.0 million, basic earnings per share increased 35.1% to $3.58, tangible book value per share increased 24.2% to $36.94, and total assets grew 9.0% to $4.02 billion. This is a standard earnings release disclosure under Item 2.02 furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 94%
filed 2026-07-16
Item 1.01
CarMax Auto Funding LLC entered into an Underwriting Agreement on July 14, 2026 to issue approximately $1.27–$1.33 billion in aggregate principal amount of asset-backed notes through CarMax Auto Owner Trust 2026-3, backed by motor vehicle retail installment sale contracts across seven note classes. The notes are anticipated to be issued on July 22, 2026, and represent a material capital-raising event through structured securitization.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-16
Item 8.01
The filing discloses the issuance of Class A(2026-1) Notes and Class A(2026-2) Notes by Capital One Multi-asset Execution Trust on July 16, 2026. This represents the creation of new direct financial obligations (debt securities) by the registrant. The disclosure of the Master Trust Transferor Interest and credit risk retention metrics further confirms this is a material debt issuance event under Item 8.01.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-07-16
EX-99.1
This is a quarterly earnings release announcing Q1 FY27 results for Wise Group plc for the quarter ending June 30, 2026. The document discloses key financial metrics including net revenue of $714.0 million (25% YoY growth), active customers of 11.9 million (21% YoY growth), cross-border volume of $69.3 billion (26% YoY growth), and provides forward guidance on FY27 net revenue growth and income before tax margin. The release includes management commentary from the CEO and notice of an earnings call, all hallmarks of a quarterly results announcement.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-16
Item 7.01
This disclosure is a company response to a Schedule 13D filing by activist investor Goldenwise Capital Group, which has demanded Board seats and challenged governance and strategy. The filing addresses Board composition, shareholder activism, and governance disputes—core governance matters. While the company disputes Goldenwise's claims and reaffirms confidence in its 2.0 Strategy, the substance is a governance dispute over Board control and leadership, not a specific governance event like an appointment, departure, or compensation arrangement. This is material because it discloses an active shareholder activism campaign that could affect Board composition and corporate control.
View raw filing on EDGAR →
6-K
Material Litigation
confidence 92%
filed 2026-07-16
EX-99.1
Brazil Potash discloses a procedural filing by the Brazilian Federal Public Defender's Office seeking to suspend provisional relief and overturn favorable court decisions regarding the Autazes Project. Although characterized as a procedural development within existing litigation rather than a new lawsuit, the filing directly threatens the Company's ability to continue installation activities on its flagship project and represents a material legal challenge that would affect a reasonable investor's assessment of project viability and timeline. The Company's detailed response and emphasis on its favorable judicial record underscore the materiality of this litigation development.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-16
Item 1.01
CrossAmerica Partners amended its Credit Agreement on July 15, 2026, extending the maturity date from March 31, 2028 to July 15, 2031, removing the SOFR credit spread adjustment, and amending financial covenants. While this is technically an amendment to an existing credit facility rather than a new issuance, it materially modifies the terms of a direct financial obligation and extends the debt maturity by three years, which is a significant capital structure event affecting the registrant's financial obligations. This falls under debt_issuance as the creation or material amendment of a direct financial obligation.
View raw filing on EDGAR →